Mysoline
Mysoline is a medicine authorised by Swissmedic under authorisation number 17885. The authorisation holder is Curatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 October 1952 and the authorisation is valid without a time limit. ATC code N03AA03 places the medicine in the group Antiepileptics.
| Authorisation number | 17885 |
|---|---|
| Name | Mysoline |
| Full name | Mysoline, Tabletten |
| Authorisation holder | Curatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AA03 |
| First authorisation | 15 October 1952 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mysoline, Tabletten | B | 15 October 1952 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 14 | 100 | Tablette(n) | N03AA03 | 01.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Mysoline authorised in Switzerland?
Yes. Mysoline is authorised by Swissmedic under authorisation number 17885, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Mysoline have?
Mysoline is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Mysoline?
The authorisation holder is Curatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.